CoChat

Microfluidic In Vitro Platform for (Nano)Safety and (Nano)Drug Efficiency Screening

Open access
Kohl, Yvonne, Biehl, Margit, Spring, Sarah, Hesler, Michelle, Ogourtsov, Vladimir, Todorovic, Miomir, Owen, Joshua, Elje, Elisabeth, Kopecka, Kristina, Moriones, Oscar Hernando, Bastús, Neus G., Simon, Peter, Dubaj, Tibor, Rundén‐Pran, Elise, Puntes, Victor, William, Nicola, von Briesen, Hagen, Wagner, Sylvia, Kapur, Nikil, Mariussen, Espen, Nelson, Andrew, Gabelova, Alena, Dusinska, Maria, Velten, Thomas, Knoll, Thorsten · 2021 · Small
Cited by 44

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Microfluidic technology is a valuable tool for realizing more in vitro models capturing cellular and organ level responses for rapid and animal‐free risk assessment of new chemicals and drugs. Microfluidic cell‐based devices allow high‐throughput screening and flexible automation while lowering costs and reagent consumption due to their miniaturization. There is a growing need for faster and animal‐free approaches for drug development and safety assessment of chemicals (Registration, Evaluation, Authorisation and Restriction of Chemical Substances, REACH). The work presented describes a microfluidic platform for in vivo‐like in vitro cell cultivation. It is equipped with a wafer‐based silicon chip including integrated electrodes and a microcavity. A proof‐of‐concept using different relevant cell models shows its suitability for label‐free assessment of cytotoxic effects. A miniaturized microscope within each module monitors cell morphology and proliferation. Electrodes integrated in the microfluidic channels allow the noninvasive monitoring of barrier integrity followed by a label‐free assessment of cytotoxic effects. Each microfluidic cell cultivation module can be operated individually or be interconnected in a flexible way. The interconnection of the different modules aims at simulation of the whole‐body exposure and response and can contribute to the replacement of animal testing in risk assessment studies in compliance with the 3Rs to replace, reduce, and refine animal experiments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/smll.202006012

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 44

Metadata

Authors
Kohl, Y., Biehl, M., Spring, S., Hesler, M., Ogourtsov, V., Todorovic, M., Owen, J., Elje, E., Kopecka, K., Moriones, O. H., Bastús, N. G., Simon, P., Dubaj, T., Rundén‐Pran, E., Puntes, V., William, N., von Briesen, H., Wagner, S., Kapur, N., Mariussen, E., Nelson, A., Gabelova, A., Dusinska, M., Velten, T., & Knoll, T.
Venue
Small
Publisher
Wiley
Published
2021-01-18
Volume
17
Issue
15
Pages
e2006012-e2006012
ISSN
  • 1613-6810 (ISSN-L)
  • 1613-6829
OpenAlex
W3123883262
Cited by
44
References
18
FWCI
2.52
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microfluidic In Vitro Platform for (Nano)Safety and (Nano)Drug Efficiency Screening. https://app.cochat.ai/papers/10.1002/smll.202006012
The paper
Kohl, Y., Biehl, M., Spring, S., Hesler, M., Ogourtsov, V., Todorovic, M., Owen, J., Elje, E., Kopecka, K., Moriones, O. H., Bastús, N. G., Simon, P., Dubaj, T., Rundén‐Pran, E., Puntes, V., William, N., von Briesen, H., Wagner, S., Kapur, N., . . . Knoll, T. (2021). Microfluidic In Vitro Platform for (Nano)Safety and (Nano)Drug Efficiency Screening. Small. https://doi.org/10.1002/smll.202006012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.